You are here
Haematopoietic Growth Factors: ESMO Clinical Practice Guidelines
J. Crawford, C. Caserta, F. Roila, on behalf of the ESMO Guidelines Working Group
Annals of Oncology 2010; 21 (Supplement 5): v248–v251
These guidelines refer to the use of haematopoietic growth factors such as granulocyte colony-stimulating factor (G-CSF) or its pegylated form (pegfilgrastim).